Autocallable Multi Barrier Reverse Convertible

Symbol: KPQXDU
ISIN: CH1317631435
Issuer:
UBS
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 98.95
Diff. absolute / % -0.15 -0.15%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Autocallable Multi Barrier Reverse Convertible
ISIN CH1317631435
Valor 131763143
Symbol KPQXDU
Quotation in percent Yes
Coupon p.a. 9.50%
Coupon Premium 8.31%
Coupon Yield 1.19%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency Swiss Franc
First Trading Date 07/02/2024
Date of maturity 07/08/2025
Last trading day 30/07/2025
Settlement Type Cash payout
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Clean
Issuer UBS

Key data

Ask Price (basis for calculation) 99.5000
Maximum yield 12.17%
Maximum yield p.a. 9.94%
Sideways yield 12.17%
Sideways yield p.a. 9.94%

market maker quality Date: 16/05/2024

Average Spread 1.01%
Last Best Bid Price 98.40 %
Last Best Ask Price 99.40 %
Last Best Bid Volume 100,000
Last Best Ask Volume 100,000
Average Buy Volume 100,000
Average Sell Volume 100,000
Average Buy Value 98,808 CHF
Average Sell Value 99,809 CHF
Spreads Availability Ratio 99.75%
Quote Availability 99.75%

Underlyings

Name Lonza Group N Roche AG Bristol-Myers Squibb Co.
ISIN CH0013841017 CH0012032048 US1101221083
Price 529.20 CHF 237.1000 CHF 40.51 EUR
Date 17/05/24 17:30 17/05/24 17:30 18/05/24 13:03
Cap 424.80 CHF 247.10 CHF 48.87 USD
Distance to Cap 102.2 -10.2 -4.96
Distance to Cap in % 19.39% -4.31% -11.30%
Is Cap Level reached No No No
Barrier 254.88 CHF 148.26 CHF 29.322 USD
Distance to Barrier 272.12 88.64 14.588
Distance to Barrier in % 51.64% 37.42% 33.22%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.